Table 4.
Linear regressions of predictors of likelihood of using PreP in the next 6 months
| n (%) | Likelihood of future PrEP use, M (SD) | Unadjusted | Adjusted | |||
| b (95% CI) | P values | b (95% CI) | P values | |||
| PEP use (last 12 months) | n=9680 | |||||
| Yes No |
758 (7.8) 8922 (92.2) |
3.87 (1.16) 2.85 (1.18) |
1.02 (0.94 to 1.11) |
<0.001 | 0.48 (0.39 to 0.57) |
<0.001 |
| STI diagnosis (last 12 months) | n=6289 | |||||
| Yes No |
1255 (20.0) 5034 (80.0) |
3.31 (1.34) 2.86 (1.20) |
0.45 (0.37 to 0.52) |
<0.001 | 0.16 (0.09 to 0.23) |
<0.001 |
| Chemsex (last 3 months) | n=9146 | |||||
| Yes No |
620 (6.8) 8526 (93.2) |
3.67 (1.25) 2.86 (1.19) |
0.81 (0.71 to 0.90) |
<0.001 | 0.39 (0.30 to 0.49) |
<0.001 |
| Happy with sex life? | n=9165 | |||||
| Very unhappy Unhappy Not sure/don’t know Happy Very happy |
438 (5.1) 1991 (22.1) 1649 (15.7) 3824 (42.4) 1263 (14.7) |
2.66 (1.27) 2.82 (1.11) 2.88 (1.19) 2.97 (1.20) 3.06 (1.40) |
0.09 (0.06 to 0.11) |
<0.001 | 0.03 (0.01 to 0.05) |
0.003 |
Note: Adjusted analyses include age, country of residence (reference group=France) and current PrEP use as covariates. Participants who responded with ‘unsure’ to having an STI diagnosis were excluded from this analysis.
PEP, post-exposure prophylaxis; PrEP, pre-exposure prophylaxis.